Scoopfeeds — Intelligent news, curated.
Which GLP-1 works best? New meta-study puts them head-to-head
politics

Which GLP-1 works best? New meta-study puts them head-to-head

The Hill · Jun 20, 2026, 2:25 PM · Also reported by 1 other source

Why this matters: political developments that affect policy direction and public trust.

The study compared three types of the medication: tirzepatide (better known under the brand names Zepbound and Mounjaro), semaglutide (sold as Wegovy and Ozempic), and liraglutide (aka Saxenda and Victoza).

Read full story on The Hill → More top stories

Also covered by

Aggregated and edited by the Scoop newsroom. We surface news from The Hill alongside other reporting so you can compare coverage in one place. Editorial policy · Corrections · About Scoop